BioCentury
ARTICLE | Company News

RaQualia gastrointestinal news

December 10, 2012 8:00 AM UTC

CJ Group (Seoul, South Korea) has exclusive rights to RaQualia's RQ-00000010 in Korea, China, Taiwan, India and Southeast Asia under a 2011 deal. In 2010, RaQualia granted CJ Group's CJ CheilJedang Co. affiliate exclusive rights to develop and commercialize RQ-00000004 in Korea and China (see BioCentury, Aug. 1, 2011). ...